TY - JOUR
T1 - Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases
AU - Dorn, Gerald W.
AU - Dang, Xiawei
N1 - Funding Information:
Funding: This research was funded by NIH R35135736, R42NS115184 and a research grant from the Muscular Dystrophy Association. The APC was funded by NIH R35135736.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Mitochondrial dynamics encompass mitochondrial fusion, fission, and movement. Mito-chondrial fission and fusion are seemingly ubiquitous, whereas mitochondrial movement is especially important for organelle transport through neuronal axons. Here, we review the roles of different mitochondrial dynamic processes in mitochondrial quantity and quality control, emphasizing their impact on the neurological system in Charcot–Marie–Tooth disease type 2A, amyotrophic lateral sclerosis, Friedrich’s ataxia, dominant optic atrophy, and Alzheimer’s, Huntington’s, and Parkinson’s diseases. In addition to mechanisms and concepts, we explore in detail different technical approaches for measuring mitochondrial dynamic dysfunction in vitro, describe how results from tissue culture studies may be applied to a better understanding of mitochondrial dysdynamism in human neurode-generative diseases, and suggest how this experimental platform can be used to evaluate candidate therapeutics in different diseases or in individual patients sharing the same clinical diagnosis.
AB - Mitochondrial dynamics encompass mitochondrial fusion, fission, and movement. Mito-chondrial fission and fusion are seemingly ubiquitous, whereas mitochondrial movement is especially important for organelle transport through neuronal axons. Here, we review the roles of different mitochondrial dynamic processes in mitochondrial quantity and quality control, emphasizing their impact on the neurological system in Charcot–Marie–Tooth disease type 2A, amyotrophic lateral sclerosis, Friedrich’s ataxia, dominant optic atrophy, and Alzheimer’s, Huntington’s, and Parkinson’s diseases. In addition to mechanisms and concepts, we explore in detail different technical approaches for measuring mitochondrial dynamic dysfunction in vitro, describe how results from tissue culture studies may be applied to a better understanding of mitochondrial dysdynamism in human neurode-generative diseases, and suggest how this experimental platform can be used to evaluate candidate therapeutics in different diseases or in individual patients sharing the same clinical diagnosis.
KW - Mitochondrial dynamics
KW - Mitofusin
KW - Neurodegenerative diseases
UR - http://www.scopus.com/inward/record.url?scp=85126599638&partnerID=8YFLogxK
U2 - 10.3390/cells11061049
DO - 10.3390/cells11061049
M3 - Review article
C2 - 35326500
AN - SCOPUS:85126599638
SN - 2073-4409
VL - 11
JO - Cells
JF - Cells
IS - 6
M1 - 1049
ER -